Abstract
Primary vesicoureteral reflux (VUR) is a common pediatric condition due to a developmental defect in the ureterovesical junction. The prevalence of VUR among individuals with connective tissue disorders, as well as the importance of the ureter and bladder wall musculature for the anti-reflux mechanism, suggest that defects in the extracellular matrix (ECM) within the ureterovesical junction may result in VUR. This review will discuss the function of the smooth muscle and its supporting ECM microenvironment with respect to VUR, and explore the association of VUR with mutations in ECM-related genes.
Similar content being viewed by others
References
Williams G, Fletcher JT, Alexander SI, Craig JC (2008) Vesicoureteral reflux. J Am Soc Nephrol 19:847–862
Tullus K (2015) Vesicoureteric reflux in children. Lancet 385:371–379
Fillion ML, Watt CL, Gupta IR (2014) Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease. Pediatr Nephrol 29:757–766
Gbadegesin RA, Brophy PD, Adeyemo A, Hall G, Gupta IR, Hains D, Bartkowiak B, Rabinovich CE, Chandrasekharappa S, Homstad A, Westreich K, Wu G, Liu Y, Holanda D, Clarke J, Lavin P, Selim A, Miller S, Wiener JS, Ross SS, Foreman J, Rotimi C, Winn MP (2013) TNXB mutations can cause vesicoureteral reflux. J Am Soc Nephrol 24:1313–1322
Elahi S, Homstad A, Vaidya H, Stout J, Hall G, Wu G, Conlon P Jr, Routh JC, Wiener JS, Ross SS, Nagaraj S, Wigfall D, Foreman J, Adeyemo A, Gupta IR, Brophy PD, Rabinovich CE, Gbadegesin RA (2015) Rare variants in tenascin genes in a cohort of children with primary vesicoureteric reflux. Pediatr Nephrol 31:247–253
Arze RS, Ramos JM, Owen JP, Morley AR, Elliott RW, Wilkinson R, Ward MK, Kerr DN (1982) The natural history of chronic pyelonephritis in the adult. Q J Med 51:396–410
el-Khatib MT, Becker GJ, Kincaid-Smith PS (1987) Morphometric aspects of reflux nephropathy. Kidney Int 32:261–266
el-Khatib MT, Becker GJ, Kincaid-Smith PS (1990) Reflux nephropathy and primary vesicoureteric reflux in adults. Q J Med 77:1241–1253
Nakashima Y, Matsuoka H, Oshima K, Sakamoto K (1997) [Progression of renal disease in patients with reflux nephropathy. Follow-up study]. Nihon Hinyokika Gakkai Zasshi 88:557–565
Bailey RR, Lynn KL, Robson RA (1994) End-stage reflux nephropathy. Ren Fail 16:27–35
Smellie JM, Barratt TM, Chantler C, Gordon I, Prescod NP, Ransley PG, Woolf AS (2001) Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial. Lancet 357:1329–1333
Becker GJ, Kincaid-Smith P (1993) Reflux nephropathy: the glomerular lesion and progression of renal failure. Pediatr Nephrol 7:365–369
Dillon MJ, Goonasekera CD (1998) Reflux nephropathy. J Am Soc Nephrol 9:2377–2383
Goonasekera CD, Gordon I, Dillon MJ (1998) 15-year follow-up of reflux nephropathy by imaging. Clin Nephrol 50:224–231
Duffield JS (2014) Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 124:2299–2306
Liu Y (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7:684–696
Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC (2003) TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284:F243–F252
Schnaper HW, Kopp JB (2003) Renal fibrosis. Front Biosci 8:e68–e86
Solari V, Owen D, Puri P (2005) Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy. J Urol 174:1609–1611, discussion 1611
Bottinger EP (2007) TGF-beta in renal injury and disease. Semin Nephrol 27:309–320
Sabasinska A, Zoch-Zwierz W, Wasilewska A, Porowski T (2008) Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol 23:769–774
Lan HY (2011) Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 7:1056–1067
Lopez-Hernandez FJ, Lopez-Novoa JM (2012) Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347:141–154
Leask A, Denton CP, Abraham DJ (2004) Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol 122:1–6
Alcaraz LB, Exposito JY, Chuvin N, Pommier RM, Cluzel C, Martel S, Sentis S, Bartholin L, Lethias C, Valcourt U (2014) Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-beta. J Cell Biol 205:409–428
Smellie JM, Prescod NP, Shaw PJ, Risdon RA, Bryant TN (1998) Childhood reflux and urinary infection: a follow-up of 10–41 years in 226 adults. Pediatr Nephrol 12:727–736
Smellie JM, Jodal U, Lax H, Mobius TT, Hirche H, Olbing H, Writing Committee IRSiC (2001) Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children. J Pediatr 139:656–663
Sjostrom S, Sillen U, Bachelard M, Hansson S, Stokland E (2004) Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol 172:694–698, discussion 699
Arlen AM, Garcia-Roig M, Weiss AD, Leong T, Cooper CS, Kirsch AJ (2015) Vesicoureteral reflux index: 2-institution analysis and validation. J Urol. doi:10.1016/j.juro.2015.03.094
Agostiniani R, Mariotti P (2011) The natural history of vesicoureteral reflux. J Matern Fetal Neonatal Med 24(Suppl 1):2–3
Roshani H, Dabhoiwala NF, Verbeek FJ, Kurth KH, Lamers WH (1999) Anatomy of ureterovesical junction and distal ureter studied by endoluminal ultrasonography in vitro. J Urol 161:1614–1619
Tanagho EA, Pugh RC (1963) The anatomy and function of the ureterovesical junction. Br J Urol 35:151–165
Yu W, Hill WG (2011) Defining protein expression in the urothelium: a problem of more than transitional interest. Am J Physiol Renal Physiol 301:F932–F942
Wu XR, Kong XP, Pellicer A, Kreibich G, Sun TT (2009) Uroplakins in urothelial biology, function, and disease. Kidney Int 75:1153–1165
Lazzeri M (2006) The physiological function of the urothelium—more than a simple barrier. Urol Int 76:289–295
Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171:493–496
Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142
Parsons CL, Stauffer C, Schmidt JD (1980) Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208:605–607
Noordzij JW, Dabhoiwala NF (1993) A view on the anatomy of the ureterovesical junction. Scand J Urol Nephrol 27:371–380
Gearhart JP, Canning DA, Gilpin SA, Lam EE, Gosling JA (1993) Histological and histochemical study of the vesicoureteric junction in infancy and childhood. Br J Urol 72:648–654
Hutch JA (1961) Theory of maturation of the intravesical ureter. J Urol 86:534–538
Oswald J, Brenner E, Schwentner C, Deibl M, Bartsch G, Fritsch H, Radmayr C (2003) The intravesical ureter in children with vesicoureteral reflux: a morphological and immunohistochemical characterization. J Urol 170:2423–2427
Oswald J, Schwentner C, Brenner E, Deibl M, Fritsch H, Bartsch G, Radmayr C (2004) Extracellular matrix degradation and reduced nerve supply in refluxing ureteral endings. J Urol 172:1099–1102
Schwentner C, Oswald J, Lunacek A, Schlenck B, Berger AP, Deibl M, Fritsch H, Bartsch G, Radmayr C (2006) Structural changes of the intravesical ureter in children with vesicoureteral reflux-does ischemia have a role? J Urol 176:2212–2218
Schwentner C, Oswald J, Lunacek A, Pelzer AE, Fritsch H, Schlenck B, Karatzas A, Bartsch G, Radmayr C (2008) Extracellular microenvironment and cytokine profile of the ureterovesical junction in children with vesicoureteral reflux. J Urol 180:694–700
Radmayr C, Fritsch H, Schwentner C, Lunacek A, Deibl M, Bartsch G, Oswald J (2005) Fetal development of the vesico-ureteric junction, and immunohistochemistry of the ends of refluxing ureters. J Pediatr Urol 1:53–59
Radmayr C, Schwentner C, Lunacek A, Karatzas A, Oswald J (2009) Embryology and anatomy of the vesicoureteric junction with special reference to the etiology of vesicoureteral reflux. Ther Adv Urol 1:243–250
Stetler-Stevenson WG (1996) Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148:1345–1350
Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:786–801
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3.12:a005058
Leonard MP, Canning DA, Epstein JI, Gearhart JP, Jeffs RD (1990) Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans. J Urol 143:1209–1212
Frey P, Lutz N, Berger D, Herzog B (1994) Histological behavior of glutaraldehyde cross-linked bovine collagen injected into the human bladder for the treatment of vesicoureteral reflux. J Urol 152:632–635
Cerwinka WH, Scherz HC, Kirsch AJ (2008) Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid in children. Adv Urol 2008:513854
Stenberg A, Larsson E, Lackgren G (2003) Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol 169:1109–1113
Alkan M, Talim B, Ciftci AO, Senocak ME, Caglar M, Buyukpamukcu N (2006) Histological response to injected gluteraldehyde cross-linked bovine collagen based implant in a rat model. BMC Urol 6:3
Routh JC, Ashley RA, Sebo TJ, Vandersteen DR, Slezak J, Reinberg Y (2007) Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux. J Urol 178:1707–1710
Arena S, Fazzari C, Implatini A, Torre S, Villari D, Arena F, Di Benedetto V (2009) Dextranomer/hyaluronic Acid copolymer implant for vesicoureteral reflux: role of myofibroblast differentiation. J Urol 181:2695–2701
Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61:198–223
Gordon MK, Hahn RA (2010) Collagens. Cell Tissue Res 339:247–257
Ottani V, Raspanti M, Ruggeri A (2001) Collagen structure and functional implications. Micron 32:251–260
Gelse K, Poschl E, Aigner T (2003) Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531–1546
Martin R, Waldmann L, Kaplan DL (2003) Supramolecular assembly of collagen triblock peptides. Biopolymers 70:435–444
Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF (1990) Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95(Pt 4):649–657
Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE (2004) Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279:53331–53337
Mouw JK, Ou G, Weaver VM (2014) Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol 15:771–785
Liu X, Wu H, Byrne M, Krane S, Jaenisch R (1997) Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 94:1852–1856
Henkel W, Glanville RW (1982) Covalent crosslinking between molecules of type I and type III collagen. The involvement of the N-terminal, nonhelical regions of the alpha 1 (I) and alpha 1 (III) chains in the formation of intermolecular crosslinks. Eur J Biochem 122:205–213
Sherratt MJ (2009) Tissue elasticity and the ageing elastic fibre. Age (Dordr) 31:305–325
Gosline J, Lillie M, Carrington E, Guerette P, Ortlepp C, Savage K (2002) Elastic proteins: biological roles and mechanical properties. Philos Trans R Soc Lond B Biol Sci 357:121–132
Kielty CM, Sherratt MJ, Shuttleworth CA (2002) Elastic fibres. J Cell Sci 115:2817–2828
Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, Yanagisawa H, Zuo J, Li T (2004) Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 36:178–182
Kielty CM (2006) Elastic fibres in health and disease. Expert Rev Mol Med 8:1–23
Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ (1991) Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J Clin Invest 87:1828–1834
Kielty CM, Shuttleworth CA (1995) Fibrillin-containing microfibrils: structure and function in health and disease. Int J Biochem Cell Biol 27:747–760
Milewicz DM, Grossfield J, Cao SN, Kielty C, Covitz W, Jewett T (1995) A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95:2373–2378
Kielty CM, Wess TJ, Haston L, Ashworth JL, Sherratt MJ, Shuttleworth CA (2002) Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil 23:581–596
Hyytiainen M, Penttinen C, Keski-Oja J (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41:233–264
Rifkin DB (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 280:7409–7412
Huang J, Davis EC, Chapman SL, Budatha M, Marmorstein LY, Word RA, Yanagisawa H (2010) Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression. Circ Res 106:583–592
Yanagisawa H, Schluterman MK, Brekken RA (2009) Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J Cell Commun Signal 3:337–347
Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122:265–278
Lethias C, Descollonges Y, Boutillon MM, Garrone R (1996) Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. Matrix Biol 15:11–19
Lethias C, Carisey A, Comte J, Cluzel C, Exposito JY (2006) A model of tenascin-X integration within the collagenous network. FEBS Lett 580:6281–6285
Bristow J, Carey W, Egging D, Schalkwijk J (2005) Tenascin-X, collagen, elastin, and the Ehlers–Danlos syndrome. Am J Med Genet C: Semin Med Genet 139C:24–30
Veit G, Hansen U, Keene DR, Bruckner P, Chiquet-Ehrismann R, Chiquet M, Koch M (2006) Collagen XII interacts with avian tenascin-X through its NC3 domain. J Biol Chem 281:27461–27470
Egging D, van den Berkmortel F, Taylor G, Bristow J, Schalkwijk J (2007) Interactions of human tenascin-X domains with dermal extracellular matrix molecules. Arch Dermatol Res 298:389–396
Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, Matsumoto K (2004) Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp Cell Res 298:305–315
Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J (1997) Tenascin-X deficiency is associated with Ehlers–Danlos syndrome. Nat Genet 17:104–108
Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL, Bristow J (2001) A recessive form of the Ehlers–Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345:1167–1175
Voermans NC, Jenniskens GJ, Hamel BC, Schalkwijk J, Guicheney P, van Engelen BG (2007) Ehlers–Danlos syndrome due to tenascin-X deficiency: muscle weakness and contractures support overlap with collagen VI myopathies. Am J Med Genet Part A 143A:2215–2219
Voermans NC, Altenburg TM, Hamel BC, de Haan A, van Engelen BG (2007) Reduced quantitative muscle function in tenascin-X deficient Ehlers–Danlos patients. Neuromuscul Disord 17:597–602
Voermans NC, Verrijp K, Eshuis L, Balemans MC, Egging D, Sterrenburg E, van Rooij IA, van der Laak JA, Schalkwijk J, van der Maarel SM, Lammens M, van Engelen BG (2011) Mild muscular features in tenascin-X knockout mice, a model of Ehlers–Danlos syndrome. Connect Tissue Res 52:422–432
Lindor NM, Bristow J (2005) Tenascin-X deficiency in autosomal recessive Ehlers–Danlos syndrome. Am J Med Genet Part A 135:75–80
Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J (2002) Tenascin-X deficiency mimics Ehlers–Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30:421–425
Egging DF, van Vlijmen I, Starcher B, Gijsen Y, Zweers MC, Blankevoort L, Bristow J, Schalkwijk J (2006) Dermal connective tissue development in mice: an essential role for tenascin-X. Cell Tissue Res 323:465–474
Zweers MC, Hakim AJ, Grahame R, Schalkwijk J (2004) Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. Arthritis Rheum 50:2742–2749
Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M, Kucharekova M, Boezeman JB, Schalkwijk J (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers–Danlos syndrome. Am J Hum Genet 73:214–217
Zweers MC, van Vlijmen-Willems IM, van Kuppevelt TH, Mecham RP, Steijlen PM, Bristow J, Schalkwijk J (2004) Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol 122:885–891
Zweers MC, Schalkwijk J, van Kuppevelt TH, van Vlijmen-Willems IM, Bergers M, Lethias C, Lamme EN (2005) Transplantation of reconstructed human skin on nude mice: a model system to study expression of human tenascin-X and elastic fiber components. Cell Tissue Res 319:279–287
Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M (1988) Tenascin interferes with fibronectin action. Cell 53:383–390
Fujie S, Maita H, Ariga H, Matsumoto K (2009) Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase activation. Biol Pharm Bull 32:1795–1799
Matsumoto K, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, Nakatsuji N, Ariga H (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6:1101–1111
Matsumoto K, Minamitani T, Orba Y, Sato M, Sawa H, Ariga H (2004) Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Exp Cell Res 297:404–414
Ikuta T, Ariga H, Matsumoto KI (2001) Effect of tenascin-X together with vascular endothelial growth factor A on cell proliferation in cultured embryonic hearts. Biol Pharm Bull 24:1320–1323
Lee BR, Silver RI, Partin AW, Epstein JI, Gearhart JP (1998) A quantitative histologic analysis of collagen subtypes: the primary obstructed and refluxing megaureter of childhood. Urology 51:820–823
Sokolis DP (2012) Multiaxial mechanical behaviour of the passive ureteral wall: experimental study and mathematical characterisation. Comput Methods Biomech Biomed Engin 15:1145–1156
Rassoli A, Shafigh M, Seddighi A, Seddighi A, Daneshparvar H, Fatouraee N (2014) Biaxial mechanical properties of human ureter under tension. Urol J 11:1678–1686
Shilo Y, Pichamuthu JE, Averch TD, Vorp DA (2014) Evaluation of the tensile strength of the human ureter—preliminary results. J Endourol 28:1470–1473
Escala JM, Keating MA, Boyd G, Pierce A, Hutton JL, Lister J (1989) Development of elastic fibres in the upper urinary tract. J Urol 141:969–973
Andersson KE, McCloskey KD (2014) Lamina propria: the functional center of the bladder? Neurourol Urodyn 33:9–16
Chang SL, Howard PS, Koo HP, Macarak EJ (1998) Role of type III collagen in bladder filling. Neurourol Urodyn 17:135–145
Aitken KJ, Bagli DJ (2009) The bladder extracellular matrix. Part I: architecture, development and disease. Nat Rev Urol 6:596–611
Macarak EJ, Howard PS (1999) The role of collagen in bladder filling. Adv Exp Med Biol 462:215–223, discussion 225–233
Callewaert B, Malfait F, Loeys B, De Paepe A (2008) Ehlers–Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 22:165–189
De Paepe A, Malfait F (2012) The Ehlers–Danlos syndrome, a disorder with many faces. Clin Genet 82:1–11
Wenstrup RJ, Florer JB, Cole WG, Willing MC, Birk DE (2004) Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers–Danlos syndrome. J Cell Biochem 92:113–124
Malfait F, Wenstrup RJ, De Paepe A (2010) Clinical and genetic aspects of Ehlers–Danlos syndrome, classic type. Genet Med 12:597–605
Malfait F, De Coster P, Hausser I, van Essen AJ, Franck P, Colige A, Nusgens B, Martens L, De Paepe A (2004) The natural history, including orofacial features of three patients with Ehlers–Danlos syndrome, dermatosparaxis type (EDS type VIIC). Am H Med Genet Part A 131:18–28
Symoens S, Malfait F, Renard M, Andre J, Hausser I, Loeys B, Coucke P, De Paepe A (2009) COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers–Danlos syndrome. Hum Mutat 30:E395–E403
Zalis EG, Roberts DC (1967) Ehlers–Danlos syndrome with a hypoplastic kidney, bladder diverticulum, and diaphragmatic hernia. Arch Dermatol 96:540–544
Burrows NP, Monk BE, Harrison JB, Pope FM (1998) Giant bladder diverticulum in Ehlers–Danlos syndrome type I causing outflow obstruction. Clin Exp Dermatol 23:109–112
Cuckow PM, Blackhall RJ, Mouriquand PD (1994) Huge bladder diverticula associated with Ehlers–Danlos syndrome. J R Soc Med 87:290–291
Levard G, Aigrain Y, Ferkadji L, Elghoneimi A, Pichon J, Boureau M (1989) Urinary bladder diverticula and the Ehlers–Danlos syndrome in children. J Pediatr Surg 24:1184–1186
Berger J, Lang E, Schaeffer EM (2007) Urological radiographic manifestations of the Ehlers–Danlos syndrome. J Urol 178:1490
Jorion JL, Michel M (1999) Spontaneous rupture of bladder diverticula in a girl with Ehlers–Danlos syndrome. J Pediatr Surg 34:483–484
Handa S, Sethuraman G, Mohan A, Sharma VK (2001) Ehlers–Danlos syndrome with bladder diverticula. Br J Dermatol 144:1084–1085
Shukla AR, Bellah RA, Canning DA, Carr MC, Snyder HM, Zderic SA (2004) Giant bladder diverticula causing bladder outlet obstruction in children. J Urol 172:1977–1979
Eadie DG, Wilkins JL (1967) Bladder-neck obstruction and the Ehlers–Danlos syndrome. Br J Urol 39:353–358
Kuivaniemi H, Peltonen L, Palotie A, Kaitila I, Kivirikko KI (1982) Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder. J Clin Invest 69:730–733
Breivik N, Refsum S Jr, Oppedal BR, Vesterhus P (1985) Ehlers–Danlos syndrome and diverticula of the bladder. Z Kinderchir 40:243–246
Schippers E, Dittler HJ (1989) Multiple hollow organ dysplasia in Ehlers–Danlos syndrome. J Pediatr Surg 24:1181–1183
Kahn T, Reiser M, Gmeinwieser J, Heuck A (1988) The Ehlers–Danlos syndrome, type IV, with an unusual combination of organ malformations. Cardiovasc Intervent Radiol 11:288–291
Bade JJ, Ypma AF, van Elk P, Mensink HJ (1994) A pelvic mass: bladder diverticulum with haemorrhage in Ehlers–Danlos patient. Scand J Urol Nephrol 28:319–321
Stage KH, Tank ES (1992) Primary congenital bladder diverticula in boys. Urology 40:536–538
Kumar S, Jayant K, Barapatra Y, Rani J, Agrawal S (2014) Giant Urinary Bladder Diverticula presenting as Epigastric Mass and Dyspepsia. Nephrourol Mon 6:e18918
Ghosh AK, O’Bryan T (1995) Ehlers–Danlos syndrome with reflux nephropathy. Nephron 70:266
Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers–Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet 77:31–37
Forleo LH, Hilario MO, Peixoto AL, Naspitz C, Goldenberg J (1993) Articular hypermobility in school children in Sao Paulo, Brazil. J Rheumatol 20:916–917
Larsson LG, Baum J, Mudholkar GS, Srivastava DK (1993) Hypermobility: prevalence and features in a Swedish population. Br J Rheumatol 32:116–119
Decoster LC, Vailas JC, Lindsay RH, Williams GR (1997) Prevalence and features of joint hypermobility among adolescent athletes. Arch Pediatr Adolesc Med 151:989–992
Rikken-Bultman DG, Wellink L, van Dongen PW (1997) Hypermobility in two Dutch school populations. Eur J Obstet Gynecol Reprod Biol 73:189–192
Remvig L, Jensen DV, Ward RC (2007) Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J Rheumatol 34:804–809
De Wandele I, Rombaut L, Malfait F, De Backer T, De Paepe A, Calders P (2013) Clinical heterogeneity in patients with the hypermobility type of Ehlers–Danlos syndrome. Res Dev Disabil 34:873–881
Remvig L, Jensen DV, Ward RC (2007) Are diagnostic criteria for general joint hypermobility and benign joint hypermobility syndrome based on reproducible and valid tests? A review of the literature. J Rheumatol 34:798–803
Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers–Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet Part A 149A:2368–2370
van Eerde AM, Verhoeven VJ, de Jong TP, van de Putte EM, Giltay JC, Engelbert RH (2012) Is joint hypermobility associated with vesico-ureteral reflux? An assessment of 50 patients. BJU Int 109:1243–1248
Pournasiri Z, Madani A, Zandi H, Salehpour S, Abdollah Gorji F, Ahmadzahe A (2014) Relationship of generalized joint hypermobility with vesicoureteral reflux and urinary tract infection. Iran J Kidney Dis 8:189–193
Beiraghdar F, Rostami Z, Panahi Y, Einollahi B, Teimoori M (2013) Vesicourethral reflux in pediatrics with hypermobility syndrome. Nephrourol Mon 5:924–927
Adib N, Davies K, Grahame R, Woo P, Murray KJ (2005) Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology (Oxford) 44:744–750
Malfait F, Hakim AJ, De Paepe A, Grahame R (2006) The genetic basis of the joint hypermobility syndromes. Rheumatology (Oxford) 45:502–507
Mohamed M, Voet M, Gardeitchik T, Morava E (2014) Cutis Laxa. Adv Exp Med Biol 802:161–184
Morava E, Guillard M, Lefeber DJ, Wevers RA (2009) Autosomal recessive cutis laxa syndrome revisited. Eur J Hum Genet 17:1099–1110
Alehossein M, Pourgholami M, Kamrani K, Soltani M, Yazdi A, Salamati P (2013) Radiologic findings in cutis laxa syndrome and unusual association with hypertrophic pyloric stenosis. Iran J Radiol 10:94–98
Agha A, Sakati NO, Higginbottom MC, Jones KL Jr, Bay C, Nyhan WL (1978) Two forms of cutis laxa presenting in the newborn period. Acta Paediatr Scand 67:775–780
Robertson SP, Bankier A (1999) Sotos syndrome and cutis laxa. J Med Genet 36:51–56
Kielty CM, Davies SJ, Phillips JE, Jones CJ, Shuttleworth CA, Charles SJ (1995) Marfan syndrome: fibrillin expression and microfibrillar abnormalities in a family with predominant ocular defects. J Med Genet 32:1–6
Robinson PN, Godfrey M (2000) The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 37:9–25
Clunie GJ, Mason JM (1962) Visceral diverticula and the Marfan syndrome. Br J Surg 50:51–52
de Silva DG, Gunawardena TP, Law FM (1996) Unusual complications in siblings with marfanoid phenotype. Arch Dis Child 75:247–248
Al-Hakim W, Goldsmith DJ (2003) Bilateral popliteal aneurysms complicating adult polycystic kidney disease in a patient with a marfanoid habitus. Postgrad Med J 79:474–475
Stromme P, Bjornstad PG, Ramstad K (2002) Prevalence estimation of Williams syndrome. J Child Neurol 17:269–271
Pober BR (2010) Williams-Beuren syndrome. N Engl J Med 362:239–252
Stoermer J, Olbing H, Hentrich F, Even K, Galal O, Bachmann J (1984) Syndrome of supravalvular aortic stenosis (Williams-Beuren syndrome) in association with changes in the kidney and efferent urinary tract. Monatsschr Kinderheilkd 132:110–112
Pober BR, Lacro RV, Rice C, Mandell V, Teele RL (1993) Renal findings in 40 individuals with Williams syndrome. Am J Med Genet 46:271–274
Pankau R, Partsch CJ, Winter M, Gosch A, Wessel A (1996) Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome. Am J Med Genet 63:301–304
Sugayama SM, Koch VH, Furusawa EA, Leone C, Kim CA (2004) Renal and urinary findings in 20 patients with Williams-Beuren syndrome diagnosed by fluorescence in situ hybridization (FISH). Rev Hosp Clin Fac Med Sao Paulo 59:266–272
Morris CA, Leonard CO, Dilts C, Demsey SA (1990) Adults with Williams syndrome. Am J Med Genet Suppl 6:102–107
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Tokhmafshan, F., Brophy, P.D., Gbadegesin, R.A. et al. Vesicoureteral reflux and the extracellular matrix connection. Pediatr Nephrol 32, 565–576 (2017). https://doi.org/10.1007/s00467-016-3386-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3386-5